Typically, patients begin their treatment with medications such as Selective Serotonin Reuptake Inhibitors (SSRIs), but prescriptions only have an initial success rate of 27.5 percent. When people do not respond to medication other therapies, Brainsway dTMS™ is a safe and effective option. This depression TMS will adjust the neural activity in the brain’s structures using a magnetic field. dTMS has been cleared by the FDA to treat anxious depression, OCD, and treatment-resistant depression.
Recent studies of dTMS show that combining dTMS with medication resulted in remission for 60 percent of the patients participating. This combination has a 445 percent higher success rate than those who relied on drugs alone.
When it comes to TMS, there is more than one option. Brainway’s Theta Burst has a Stanford Accelerated Intelligent Neuromodulation Therapy or Saint TMS protocol. This protocol can treat Major Depressive Disorder as well as treatment-resistant depression.
Theta Burst is a much shorter session that lasts roughly three to four minutes. With the SAINT protocol, the targeted and intermittent bursts of magnetic frequencies help stimulate neurons, effectively reducing severe depression and suicidal ideation symptoms.
Both Saint TMS and the dTMS are safe and noninvasive. No recovery time is necessary with TMS because no anesthesia is administered. As a result, most patients can easily work the treatments into their schedules.